“Generic and Branded Pomalidomide Equally Effective, Safe for Relapsed Myeloma in Chinese Patients”

https://pubmed.ncbi.nlm.nih.gov/38112795

This study found that generic pomalidomide plus low-dose dexamethasone showed similar efficacy and safety to branded pomalidomide in treating relapsed or refractory multiple myeloma in Chinese patients.